Consider also that this study was conducted primarily in THP‐1, a cell line derived from infant AML with MLL‐AF9, meaning that the results are not generalisable to patients from older cohorts or with differing molecular profiles. This evidence concerns the gene KMT2A and acute myeloid leukemia.